Integra Lifesciences Holdings (IART) Invested Capital (2009 - 2026)

Integra Lifesciences Holdings' Invested Capital history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Invested Capital fell 22.83% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (down 22.83% YoY), while the FY2025 annual figure was $1.8 billion, down 23.23% from the prior year.
• Invested Capital came in at $1.8 billion for Q1 2026 at Integra Lifesciences Holdings, down from $1.8 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.6 billion in Q4 2022 to a low of $1.8 billion in Q1 2026.
• A 5-year average of $2.3 billion and a median of $2.4 billion in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital advanced 2.01% in 2022 and dropped 23.23% in 2025, its largest moves.
• Integra Lifesciences Holdings' Invested Capital stood at $2.6 billion in 2022, then declined by 8.39% to $2.4 billion in 2023, then slipped by 2.42% to $2.3 billion in 2024, then decreased by 23.23% to $1.8 billion in 2025, then slipped by 0.61% to $1.8 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $1.8 billion, $1.8 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison